Isocitrate dehydrogenase 1 (IDH1) mutation is reported as a gain-of-function mutation in up to 25% of cholangiocarcinoma, especially intrahepatic cholangiocarcinoma [7, 8]. Here, IDH1 is linked to cholangiocarcinoma.